Ahmed Magdy Rabea/LinkedIn
May 12, 2025, 13:37
Ahmed Magdy Rabea: EGFR Mutant Treatment in Metastatic NSCLC at Lung360 Meeting
Ahmed Magdy Rabea, Assistant Professor of Medical Oncology and Hematology at National Cancer Institute, shared a post on LinkedIn by CAIRO Journal Club adding:
“A part of the enjoyable debate and discussion about the EGFR mutant treatment landscape in metastatic NSCLC with my friend Amr Shafik Saad during the Lung360 meeting.”
Quoting CAIRO Journal Club’s post below:
“Highlights from the powerful edition of the Lung Cancer 360° Forum – Seventh Edition
Thank you to everyone who made it impactful.”
Read more posts featuring Ahmed Magdy Rabea.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 20, 2025, 20:20
Jul 20, 2025, 20:10
Jul 20, 2025, 19:54
Jul 20, 2025, 19:20
Jul 20, 2025, 18:59
Jul 20, 2025, 18:27
Jul 20, 2025, 18:12
Jul 20, 2025, 17:37